Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.6845
+0.0598 (9.57%)
At close: Apr 15, 2026, 4:00 PM EDT
0.6924
+0.0079 (1.15%)
After-hours: Apr 15, 2026, 7:03 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Research and Development of Innovative Cancer Therapeutics | 9.44M | 10.91M | 10.02M | 10.16M | 10.65M | | | | | |
Research and Development of Innovative Cancer Therapeutics Growth | -13.43% | 8.83% | -1.37% | -4.57% | -1.72% | | | | | |
| 9.44M | 10.91M | 10.02M | 10.16M | 10.65M | | | | | |
| -13.43% | 8.83% | -1.37% | -4.57% | -1.72% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 9.44M | 10.91M | 10.02M | 10.16M | 10.65M | | | | | |
| -13.43% | 8.83% | -1.37% | -4.57% | -1.72% | | | | | |
| 9.44M | 10.91M | 10.02M | 10.16M | 10.65M | | | | | |
| -13.43% | 8.83% | -1.37% | -4.57% | -1.72% | | | | | |
Source: S&P Global Market Intelligence.
